Download PDF
Thromb Haemost 1960; 4(01): 071-082
DOI: 10.1055/s-0038-1654489
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Influence of Blood Corpuscles on Clot Firmness: Thrombelastographic Observations

Francesco De Matteis
1   Institute of Clinical Medicine, University of Bari (Director: Prof. V. Chini)
,
Nicoletta Vulpis
1   Institute of Clinical Medicine, University of Bari (Director: Prof. V. Chini)
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2018 (online)

    Permissions and Reprints

Summary

Red and white corpuscles cause a reduction in maximal amplitude values of thrombelastographic tracings. This is due to an inhibition of clot firmness. In this work the quantitative relation between maximal amplitude reduction and cell volume was proved experimentally. It was also investigated how blood cells cause the observed modifications in t.e.graphic tracings.

 

  • References

  • (1) Budtz-Olsen O. E. Clot retraction. Blackwell Scientific Publications; Oxford: 1951
    Google Scholar
  • (2) Della Santa R, Duraffourd P. Ber. Int. Kongr. Thrombose u. Embolie. Basel: 1954
    Google Scholar
  • (3) Hartert H. Die Thrombelastographie. Eine Methode zur physikalischen Analyse des Blutgerinnungsvorganges. Z. ges. exp. Med. 117: 189 1951;
    CrossrefPubMedGoogle Scholar
  • (4) Hörder M. H, Pileggi J. Beeinflussung der Haftfähigkeit des Thrombus durch Leukozyten der chronisch leukämischen Myelose. Acta haemat. (Basel) 17: 111 1957;
    CrossrefPubMedGoogle Scholar
  • (5) Marmont A, Palmieri A, Giacca S. Suile modificazioni quantitative provocate dalla somministrazione endovenosa di eparina sulla piastrinemia capillare e venosa delPuomo. Atti del 1° Simposio sui problemi attinenti alla Coagulazione dei sangue. Genova: dicembre 1953: 428.
    Google Scholar
  • (6) Tocantins L. M. The coagulation of blood. Methods of Study. Gruñe & Stratton. 1955: 155.
    PubMedGoogle Scholar
  • (7) Vulpis N, De Matteis F. Attività trombelastografica del siero immune antipiastrine. Policlinico, Sez. med. 65: 269 1958;
    PubMedGoogle Scholar
  • (8) Ware A. G, Guest M. M, Seegers W. H. Fibrinogen: With Special Reference to its Preparation and Certain Properties of its Products. Arch. Biochem. 13: 231 1947;
    PubMedGoogle Scholar
  • (9) Weiner M, Weisberg L. G. Clot firmness. Blood 12: 1125 1957;
    PubMedGoogle Scholar
  • (10) Winckelmann G, Hörder M. H. Veränderung der Gerinnselhaftfähigkeit durch Leukozyten der myeloischen Reihe. Thrombelastographische Untersuchungen bei chronischen myeloischen Leukämien, akuten Urämien und reaktiven Leukozytosen. Acta haemat. (Basel) 18: 261 1957;
    CrossrefPubMedGoogle Scholar